Table 4 Mean sub-scales scores of KDQOL
From: Educational supportive group therapy and the quality of life of hemodialysis patients
Mean ± SD | P**Value | ||||
|---|---|---|---|---|---|
Group | Pre | Post | Follow up | ||
Symptom/Problem list(S/PL) | Control | 40.08 ± 7.84 | 40.67 ± 10.48 | 41.33 ± 11.14 | 0.819 |
Experimental | 39.85 ± 7.57 | 46.83 ± 14.31 | 47.62 ± 14.86 | 0.031 | |
P*value | 0.798 | 0.118 | 0.122 | ||
Effects of kidney disease (EKD) | Control | 29.27 ± 9.62 | 29.27 ± 9.27 | 28.85 ± 9.67 | 0.549 |
Experimental | 31.3 ± 6.41 | 40.41 ± 12.38 | 41.77 ± 11. 6 | 0.0001 | |
P*value | 0.34 | 0.0001 | 0.0001 | ||
Burden of kidney disease (BKD) | Control | 32.71 ± 14.92 | 34.58 ± 14.93 | 33.96 ± 16.06 | 0.247 |
Experimental | 35.83 ± 10.12 | 41.95 ± 10.41 | 43.23 ± 10.59 | 0.012 | |
P*value | 0.405 | 0.124 | 0.708 | ||
Work Status (WS) | Control | 18.33 ± 21.71 | 22.5 ± 22.12 | 22.5 ± 23.07 | 0.016 |
Experimental | 18.33 ± 15.99 | 25 ± 18.57 | 25 ± 17.37 | 0.066 | |
P*value | 0.749 | 0.605 | 0.588 | ||
Cognitive function (CF) | Control | 45.55 ± 16.16 | 49.55 ± 16.32 | 47.8 ± 15.16 | 0.006 |
Experimental | 46.03 ± 10.72 | 56.45 ± 8.01 | 56.13 ± 8.28 | 0.0001 | |
P*value | 0.952 | 0.137 | 0.026 | ||
Quality of social interaction (QSI) | Control | 60.44 ± 18.69 | 59.77 ± 19.85 | 57.33 ± 19.62 | 0.368 |
Experimental | 60.54 ± 17.75 | 63.43 ± 15.62 | 61.04 ± 17.76 | 0.64 | |
P*value | 0.782 | 0.81 | 0.77 | ||
Sexual function (SexF) | Control | 41 ± 11.25 | 40.83 ± 10.99 | 40.83 ± 10.99 | 0.368 |
Experimental | 40.42 ± 6.2 | 44.08 ± 7.58 | 44.5 ± 6.1 | 0.0001 | |
P*value | 0.643 | 0.066 | 0.046 | ||
Sleep (S) | Control | 49.17 ± 14.15 | 50 ± 13.34 | 47.83 ± 15.63 | 0.016 |
Experimental | 47.13 ± 12.43 | 53.67 ± 12.65 | 59.13 ± 12.56 | 0.0001 | |
P*value | 0.051 | 0.056 | 0.004 | ||
Social support (SS) | Control | 30.72 ± 12.8 | 31 ± 11.4 | 31.72 ± 12.27 | 0.488 |
Experimental | 31.19 ± 6.42 | 36.88 ± 6.29 | 39.91 ± 7.6 | 0.0001 | |
P*value | 0.546 | 0.005 | 0.003 | ||
Dialysis staff encouragement (DSE) | Control | 37.96 ± 8.93 | 40.31 ± 9.5 | 41.14 ± 9.09 | 0.018 |
Experimental | 40.37 ± 11.07 | 45.93 ± 8.13 | 48.56 ± 6.94 | 0.0001 | |
P*value | 0.881 | 0.003 | 0.0001 | ||
Patient satisfaction (PS) | Control | 39 ± 22.07 | 41 ± 13.48 | 39.17 ± 10.35 | 0.379 |
Experimental | 41.21 ± 17.08 | 54.87 ± 17.08 | 56.09 ± 18.82 | 0.0001 | |
P*value | 0.453 | 0.002 | 0.0001 | ||
Physical functioning (PF) | Control | 38.17 ± 10.46 | 37.67 ± 11.65 | 36.5 ± 10.18 | 0.247 |
Experimental | 39.5 ± 11.09 | 41.67 ± 10.69 | 43.81 ± 9.71 | 0.003 | |
P*value | 0.317 | 0.029 | 0.003 | ||
Role-Physical limitation (RPL) | Control | 21.67 ± 25.2 | 23.33 ± 25.37 | 21.67 ± 25.2 | 0.368 |
Experiment | 20.83 ± 13.27 | 29.17 ± 11.53 | 31.67 ± 18.49 | 0.014 | |
P*value | 0.543 | 0.085 | 0.04 | ||
Pain (P) | Control | 31.66 ± 10.24 | 30.42 ± 10.21 | 31.75 ± 10.57 | 0.867 |
Experimental | 31.75 ± 9.76 | 36.33 ± 9.3 | 35.75 ± 9.19 | 0.006 | |
P*value | 0.782 | 0.033 | 0.154 | ||
General health (GH) | Control | 39 ± 12.06 | 37.67 ± 12.44 | 37.5 ± 12.3 | 0.368 |
Experimental | 42.61 ± 7.12 | 46.19 ± 4.27 | 51.69 ± 5.12 | 0.0001 | |
P*value | 0.635 | 0.041 | 0.0001 | ||
Emotional well-being (EW) | Control | 40.4 ± 19.05 | 42.17 ± 19.76 | 43.8 ± 21.05 | 0.004 |
Experimental | 38.87 ± 5.82 | 47.33 ± 3.94 | 49.15 ± 6.33 | 0.0001 | |
P*value | 0.995 | 0.282 | 0.35 | ||
Role-emotional limitation (REL) | Control | 21.10 ± 18.53 | 22.22 ± 23.7 | 21.22 ± 22.19 | 0.931 |
Experimental | 22.22 ± 15.98 | 23.33 ± 17.83 | 25.55 ± 14.34 | 0.81 | |
P*value | 0.724 | 0.643 | 0.306 | ||
Social function (SocF) | Control | 38.6 ± 4.63 | 39.66 ± 4.35 | 42.81 ± 6.08 | 0.007 |
Experimental | 37.55 ± 5.21 | 43.38 ± 9.51 | 47.54 ± 8.67 | 0.0001 | |
P*value | 0.089 | 0.003 | 0.006 | ||
Energy/fatigue (E/F) | Control | 36.53 ± 9.1 | 39.87 ± 7.94 | 37.87 ± 9.47 | 0.521 |
Experimental | 38.4 ± 8.81 | 45.73 ± 9.88 | 44.83 ± 10.10 | 0.0001 | |
P*value | 0.509 | 0.0001 | 0.007 | ||